This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.
Mayuko Nagae, Yoshihisa Uenoyama, Saki Okamoto, Hitomi Tsuchida, Kana Ikegami, Teppei Goto, Sutisa Majarune, Sho Nakamura, Makoto Sanbo, Masumi Hirabayashi, Kenta Kobayashi, Naoko Inoue, Hiroko ...
NEW ORLEANS -- Off-label use of oral elagolix (Orilissa) may be a more patient-friendly alternative to standard-of-care injectable GnRH antagonists for ovulation suppression during in vitro ...
Testosterone recovery in patients with prostate cancer treated with radiotherapy and different ADT duration: Long-term data from two randomized trials. 10-Year efficacy and co-morbidity outcomes of a ...
Two Sealed Airtight Medical Vials Against Bright Background Front View. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations.
A 28-year-old nulliparous woman presents for follow-up with the chief complaint of persistent dysmenorrhea that was progressing and severe dyspareunia. At age 16, she first reported heavy menstrual ...
(Little Rock, KATV) — Here are the biggest news stories that had you all talking during the week of July 24 - July 30: Earlier this month, the U.S. Food and Drug Administration added a warning to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback